As demonstrated, serotonin receptor mRNAs and proteins are expressed across diverse cancer types, and pharmacological inhibition of 5-HT receptors leads to activation of the p53 DNA damage pathway and suppression of MAPK activity [52]. Here, TP53 is linked to cancer.